Skip to main content
Ind-Swift Laboratories Ltd. logo

Ind-Swift Laboratories Ltd. — Investor Relations & Filings

Ticker · INDSWFTLAB ISIN · INE915B01019 LEI · 335800ZT8UFD9Y8ZMP56 BSE.NS Manufacturing
Open in API
Filings indexed 809 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country IN India
Listing BSE.NS INDSWFTLAB

About Ind-Swift Laboratories Ltd.

https://www.indswiftlabs.com

Ind-Swift Laboratories Ltd. is a global manufacturer specializing in Active Pharmaceutical Ingredients (APIs) and Advanced Intermediates. The company focuses on research and development, process chemistry, and large-scale production across diverse therapeutic segments, including macrolide antibiotics, cardiovascular agents, antihistamines, antidiabetics, and antipsychotics. Operating multiple manufacturing facilities that adhere to international regulatory standards such as USFDA, EDQM, and PMDA, the organization provides high-quality chemical entities to the global market. Its core competencies lie in complex chemical synthesis and the development of cost-effective manufacturing processes for generic and specialty drug substances. The company maintains a strong emphasis on quality assurance and regulatory compliance to support its extensive portfolio of products distributed worldwide.

Recent filings

Filing Released Lang Actions
Ind-Swift Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve and take on record Standalone ....
Regulatory Filings Classification · 85% confidence The document is a notice of a board meeting to consider and approve the audited financial results, sent to stock exchanges under SEBI LODR regulations. It does not itself contain financial results, management changes, or detailed report data. It is a general regulatory announcement/compliance filing. Therefore it falls under the Regulatory Filings (RNS) category.
2026-05-22 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 85% confidence The document is a stock exchange filing under SEBI (Substantial Acquisition of Shares & Takeover) Regulations 2011, disclosing that the promoters have not created any encumbrance during the year. This is a mandatory regulatory compliance announcement to the exchanges, not a financial report, management discussion, director trade, or other specialized notice. It fits the “Regulatory Filings” fallback category for compliance disclosures under stock exchange/SEBI rules.
2026-05-19 English
Monitoring Agency Report
Regulatory Filings Classification · 85% confidence The document is a Monitoring Agency Report filed under SEBI Listing Regulations for the quarter ended March 31, 2026, detailing the utilisation of proceeds from a preferential issue. It does not contain financial statements (so it’s not an interim or annual report), nor is it an earnings release or management presentation. It is a regulatory compliance filing disclosing monitoring agency findings, fitting the “Regulatory Filings (RNS)” category for miscellaneous compliance disclosures.
2026-05-15 English
Please find enclosed report of the Monitoring Agency for the quarter ended March 31, 2026.
Capital/Financing Update Classification · 85% confidence The document is the Monitoring Agency Report for the quarter ended March 31, 2026, required under SEBI regulations in respect of proceeds raised via a preferential issue. It is not an interim or annual financial statement, nor a simple announcement, but a statutory update on the utilisation of capital raised. Therefore it falls under Capital/Financing Update (CAP).
2026-05-15 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed disclosure of voting results from a Postal Ballot conducted by Ind-Swift Laboratories Limited. It includes the resolutions passed, voting percentages, and the scrutinizer's report as required under the Companies Act, 2013 and SEBI Listing Regulations. The content focuses on the official announcement of shareholder voting outcomes and the related scrutinizer's certification, rather than the minutes of a meeting or management discussion. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document is lengthy and contains detailed voting data, not just a brief announcement or a reference to a report, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Therefore, the correct classification is DVA with high confidence.
2026-05-05 English
General Updates
Major Shareholding Notification Classification · 100% confidence The document is a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, regarding the disposal of a substantial number of shares (7.5%) by HCP Investments in Ind Swift Laboratories Limited. This type of filing is a notification of a major shareholding change, specifically a substantial acquisition or disposal of shares as per regulatory requirements. The document does not contain financial statements, management discussion, or other report content, but is a formal notification of shareholding changes. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length is 2413 characters, which is consistent with a notification rather than a full report.
2026-04-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.